News

The U.S. Food and Drug Administration has declined to approve Capricor Therapeutics' cell therapy for a heart condition, the ...
Capricor Therapeutics plummeted Friday after the FDA rejected its experimental treatment for cardiomyopathy associated with ...
A labeling mistake has led to a nationwide recall of four different types of Ritz Peanut Butter Cracker Sandwich cartons, ...
At least one person has died and 134 have been infected from an outbreak of salmonella linked to a recall of more than 20 ...
British American Tobacco's rally is driven by market leadership in vaping, improved margins, and bullish sentiments. Find out ...
Two brothers from India were each sentenced to 30 months in prison for a scheme to sell counterfeit and adulterated drugs in ...
A recall of thousands of cases of fruits and vegetables has been issued due to potential fluid contamination—the ...
The FDA has approved a groundbreaking new therapy for patients battling late-stage melanoma, offering hope when options run out.
A new dosing regimen for Kisunla, to help lower the risk of certain side effects, has been approved by the U.S. Food and Drug ...
Synchrony Medical announced that it received FDA 510 (k) clearance for its LibAirty airway clearance system.
The sandwiches were available at micro markets and vending machines in all of Ohio, Eastern Indiana and Northern Kentucky.
In its complete response letter, the FDA cited insufficient evidence establish deramiocel's effectiveness for cardiomyopathy ...